PFE Pfizer Inc. logo

PFE Pfizer Inc.

Healthcare
$25.90-0.19%ClosedMarket Cap: $147.62B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

19.91

PEG

P/B

1.64

P/S

2.33

EV/EBITDA

12.42

DCF Value

$38.72

FCF Yield

6.4%

Div Yield

6.6%

Margins & Returns

Gross Margin

69.3%

Operating Margin

23.4%

Net Margin

11.8%

ROE

8.4%

ROA

3.6%

ROIC

8.0%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$14.45B$2.69B$
Q4 null$17.56B$-1.65B$
FY null$62.58B$7.77B$
Q3 null$16.65B$3.54B$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$26.78

Target (Median)

$27.00

Target Range

$25.00 - $30.00

2 Strong Buy9 Buy15 Hold1 Sell2 Strong Sell
CitigroupNeutral
2026-04-29
RBC CapitalUnderperform
2026-04-20
UBSNeutral
2026-04-13
Morgan StanleyEqual Weight
2026-04-10
B of A SecuritiesNeutral
2026-04-09

Trading Activity

Insider Trades

View All
BOURLA ALBERTdirector, officer: Chairman & CEO
SellMon May 18
BOURLA ALBERTdirector, officer: Chairman & CEO
SellMon May 04
Quincey Jamesdirector
SellMon Apr 27
NORA JOHNSON SUZANNE Mdirector
SellMon Apr 27
NARAYEN SHANTANUdirector
SellMon Apr 27

Congress Trades

View All
Ro KhannaBuy
Wed May 13
Susan M. CollinsBuy
Wed Mar 25

Company Info

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

US

Exchange

Beta

0.30

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Peers